Alignment Healthcare, Inc.ALHCEarnings & Financial Report
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Revenue
$628.6M
Gross Profit
N/A
Operating Profit
$-41.1M
Net Profit
$-46.5M
Gross Margin
N/A
Operating Margin
-6.5%
Net Margin
-7.4%
YoY Growth
44.6%
EPS
$-0.25
Alignment Healthcare, Inc. Q1 FY2024 Financial Summary
Alignment Healthcare, Inc. reported revenue of $628.6M (up 44.6% YoY) for Q1 FY2024, with a net profit of $-46.5M (down 24.8% YoY) (-7.4% margin).
Key Financial Metrics
| Total Revenue | $628.6M |
|---|---|
| Net Profit | $-46.5M |
| Gross Margin | N/A |
| Operating Margin | -6.5% |
| Report Period | Q1 FY2024 |
Alignment Healthcare, Inc. Annual Revenue by Year
Alignment Healthcare, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.9B).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.9B |
| 2024 | $2.7B |
| 2023 | $1.8B |
| 2022 | $1.4B |
Alignment Healthcare, Inc. Quarterly Revenue & Net Profit History
Alignment Healthcare, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.0B | +44.4% | $-11.0M | -1.1% |
| Q3 FY2025 | $993.7M | +43.5% | $3.7M | 0.4% |
| Q2 FY2025 | $1.0B | +49.0% | $15.7M | 1.5% |
| Q1 FY2025 | $926.9M | +47.5% | $-9.1M | -1.0% |
| Q4 FY2024 | $701.2M | +52.8% | $-31.1M | -4.4% |
| Q3 FY2024 | $692.4M | +53.8% | $-26.4M | -3.8% |
| Q2 FY2024 | $681.3M | +49.1% | $-24.0M | -3.5% |
| Q1 FY2024 | $628.6M | +44.6% | $-46.5M | -7.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $628.6M | $681.3M | $692.4M | $701.2M | $926.9M | $1.02B | $993.7M | $1.01B |
| YoY Growth | 44.6% | 49.1% | 53.8% | 52.8% | 47.5% | 49.0% | 43.5% | 44.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $633.2M | $716.3M | $692.3M | $782.1M | $895.6M | $1.00B | $1.10B | $1.07B |
| Liabilities | $501.2M | $591.5M | $576.7M | $681.1M | $786.6M | $859.2M | $940.7M | $886.5M |
| Equity | $130.9M | $123.7M | $114.5M | $99.9M | $108.1M | $141.0M | $161.9M | $179.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-6.2M | $23.5M | $26.2M | $-8.7M | $16.6M | $29.1M | $144.6M | $-50.4M |